Peripheral Vascular Devices Market

Peripheral Vascular Devices Market Size:

The global peripheral vascular devices market size reached USD 11.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach USD 19.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.9% during 2024-2032. The market growth is significantly propelled by ongoing innovations in minimally invasive procedures and amplifying prevalence of cardiovascular disorders. Moreover, demand for atherectomy devices, stents, and angioplasty balloons is heightening as healthcare providers emphasize on enhancing patient outcomes, driving substantial market expansion across medical industry.

Peripheral vascular disease (PVD) is a circulatory condition caused due to the narrowing, blockage, or spasms in the blood vessels located outside the heart and brain. Such occurrences reduce the blood flow through the vessels, resulting in weakness, pain, gangrene, hair loss on the legs, numbness, and muscle heaviness. Peripheral vascular devices, such as angioplasty catheters, peripheral guidewires, vena cava filters, stent grafts, and embolic protection devices (EPD), are used to treat artery blockages and narrowing. These blockages, particularly found in the peripheral vasculature, are caused by plaque build-up, which limits the blood vessels and reduces blood flow to the body parts. Peripheral vascular devices are safe, minimize the risk of infection and irritation, improve blood flow, and supply oxygenated blood through arteries.

Peripheral Vascular Devices Market Trends:

Heightening Demand for Minimally Invasive Procedures

The global peripheral vascular devices market is witnessing an escalating demand for minimally invasive procedures, primarily driven by the requirement for cost-effectiveness, minimized recovery times, and reduced complication rates. Devices like atherectomy systems, stents, and angioplasty balloons are rapidly gaining momentum due to their capability to treat peripheral artery diseases with reduced trauma to the patient. Moreover, as healthcare patients and providers are increasingly opting for such procedures, innovations in technology are rapidly growing to improve the accuracy and efficacy of such devices. In addition, this trend is boosting the market expansion, particularly as healthcare systems are currently focusing on patient-specific treatments and successful outcomes. As per industry reports, the minimally invasive surgery devices market is anticipated to expand from USD 14.06 billion in 2023 to USD 28.483 billion by the year 2032. 

Technological Innovations in Vascular Devices

The peripheral vascular devices market analysis indicates that constant technological advancements are significantly steering the global market expansion. Innovations, such as enhanced imaging techniques, drug-coated balloons, and bioresorbable stents, are improving the efficacy of treatments for peripheral vascular diseases. According to a research article published in the journal Cardiovascular Interventions, in May 2023, drug-coated balloons (DCBs) attained a 5-year freedom from reintervention procedures of 58% for in-stent restenosis, a condition associated with peripheral vascular diseases. Moreover, such advancements facilitate more accurate interventions, enhance patient outcomes, and lower the requirement for repeat procedures. In addition, the increasing incorporation of digital health solutions, such as data analytics and remote monitoring, is enabling better management of chronic vascular disorders. Furthermore, as manufacturers are heavily investing in research and development projects to bring leading-edge solutions to the market, the overall need for upgraded peripheral vascular devices is stably escalating.

Rising Prevalence of Peripheral Artery Disease (PAD)

The peripheral vascular devices market research indicates that the amplifying prevalence of peripheral artery disease (PAD) is a crucial driver of the global market. With an elevation in aging population and the heightening incidents of risk factors, such as smoking, diabetes, and hypertension, PAD cases are gradually becoming more prevalent globally. According to the International Diabetes Federation, the number of individuals suffering with diabetes will elevate to 643 million by 2030 and 783 million by the year 2045. Moreover, this accelerating patient pool is bolstering the demand for efficient vascular devices to treat as well as manage the condition. In addition, as awareness of PAD is notably fueling worldwide among both patients and healthcare providers, early diagnosis and intervention are also surging. Resultantly, there is a proliferating market for angioplasty balloons, stents, and various other devices developed to mitigate arterial blockages and enhance circulation, substantially contributing to the peripheral vascular devices market growth.

Peripheral Vascular Devices Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on device type and end user.

Breakup by Device Type:

• Peripheral Vascular Stents
• Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
• Peripheral Transluminal Angioplasty (PTA) Guidewires
• Atherectomy Devices
• Embolic Protection Devices
• Inferior Vena Cava Filters
• Others
   

Peripheral vascular stents accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the device type. This includes peripheral vascular stents, peripheral transluminal angioplasty (PTA) balloon catheters, peripheral transluminal angioplasty (PTA) guidewires, atherectomy devices, embolic protection devices, inferior vena cava filters, and others. According to the report, peripheral vascular stents represented the largest segment.

Breakup by End User:

• Hospitals and Clinics
• Ambulatory Care Centers
• Specialty Clinics
• Others
   

Hospitals and clinics hold the largest share of the industry

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals and clinics, ambulatory care centers, specialty clinics, and others. According to the report, hospitals and clinics accounted for the largest market share.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

North America leads the market, accounting for the largest peripheral vascular devices market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for peripheral vascular devices.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global peripheral vascular devices market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

• Abbott Laboratories
• B. Braun SE (B. Braun Holding GmbH & Co. KG)
• Becton, Dickinson and Company
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cook Group Incorporated
• Cordis Corporation
• iVascular S.L.U.
• Koninklijke Philips N.V.
• Medtronic plc
• Terumo Medical Corporation
   

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Peripheral Vascular Devices Market News:

• In April 2024, Abbott announced the receival of FDA approval for an innovative, first-of-its-kind Esprit BTK Everolimus Eluting Resorbable Scaffold System, a dissolvable stent specially designed for below-the-knee chronic limb-threatening ischemia disease, an acute form of peripheral artery disease.
• In May 2024, BD Life Sciences announced the commencement of a clinical trial for its self-expanding vascular covered stent, designed for peripheral arterial disease and coated with fluoropolymer.

Peripheral Vascular Devices Market Report Scope:

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the peripheral vascular devices market from 2018-2032.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the global peripheral vascular devices market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the peripheral vascular devices industry and its attractiveness.
• The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.